[ad_1] ARVO meeting abstract just published: Ocular Pharmacokinetics and Safety of Suprachoroidal A01017, Small Molecule Complement Inhibitor, Injectable Suspension in Rabbits | IOVS | ARVO Journals https://t.co/FC85W5jD07 #retina #eyes #ophthalmology #optometry From Danobeiti 2014: https://t.co/mr49Lnel35 [ad_2] Source by Thomas Ciulla, MD, MBA Return to main …

[ad_1] Just presented at ARVO: Suprachoroidal CLS-AX (axitinib injectable suspension), as a Potential Long-Acting Therapy for Neovascular Age-Related Macular Degeneration (nAMD) | IOVS | ARVO Journals https://t.co/OigBzx215J #retina #eyes #ophthalmology #ophthalmologist #optometry https://t.co/WWv4RJYvGk [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.

[ad_1] Treatment Burden and Visual Outcomes in Neovascular Age-Related Macular Degeneration (AMD) | IOVS | ARVO Journals https://t.co/y3AGPDf6un [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.

[ad_1] Visual Acuity Outcomes and Anti-Vascular Endothelial Growth Factor Therapy Intensity in Macular Edema Due to Retinal Vein Occlusion: A Real World Analysis of 12,214 Eyes. | IOVS | ARVO Journals https://t.co/4mTZQomaF6 [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.

[ad_1] Lean Six Sigma concepts can reduce waste and enhance patient care. Our paper in this month’s OSLI Retina was recently featured. Evolution of Primary Scleral Buckling Surgery: A Modified Lean Six Sigma Technique to Improve Surgical Efficiency https://t.co/NalbwxNi7N https://t.co/lIUyalqbpG [ad_2] Source by Thomas Ciulla, …

[ad_1] Recently published…Diabetic macular edema, a leading cause of vision loss, is treated less intensely and shows worse outcomes than in clinical trials. More effective and longer acting therapies are needed. A Real-World Analysis of 28,658 Patient Eyes… https://t.co/0urP9sJjdl [ad_2] Source by Thomas Ciulla, MD, …

[ad_1] RT @RetinaToday: Today’s throwback article is from August 2019 where Thomas A. Ciulla, MD, MBA, took a look at clinical research teams work… [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.